Is Poseida Therapeutics Inc (PSTX) Stock at the Top of the Biotechnology Industry?

Poseida Therapeutics Inc (PSTX) is near the top in its industry group according to InvestorsObserver. PSTX gets an overall rating of 62. That means it scores higher than 62 percent of stocks. Poseida Therapeutics Inc gets a 82 rank in the Biotechnology industry. Biotechnology is number 73 out of 148 industries.

PSTX has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on PSTX!

See Full PSTX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Poseida Therapeutics Inc Stock Today?

Poseida Therapeutics Inc (PSTX) stock has risen 2.95% while the S&P 500 is down -0.54% as of 1:23 PM on Friday, Oct 20. PSTX is higher by $0.07 from the previous closing price of $2.37 on volume of 455,233 shares. Over the past year the S&P 500 is higher by 16.07% while PSTX is down -35.62%. PSTX lost -$0.24 per share the over the last 12 months. Click Here to get the full Stock Report for Poseida Therapeutics Inc stock.